Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pleconaril Nasal Spray for Asthma Exacerbations
NCT00394914Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in rhinovirus infection and common cold comparing Pleconaril with Placebo (2 arms). Primary endpoints: Percentage of Participants With Rhinovirus PCR-Positive Colds at 21 days and Percentage of Participants With Asthma Exacerbations Together With Rhinovirus-Positive PCR at 21 days. Started Aug 2006; status: completed.
02
Drugs
pleconaril
03
Conditions
rhinovirus infectioncommon cold
Beyond the preview
Go deeper on NCT00394914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394914.